Bair N - Search Results

1

Effect of Weight on Parenteral Prostacyclin Analogues Dosing in Pulmonary Hypertension.

Raeisi-Giglou P, Wang XF, Dakkak W, Bair N, Dweik RA, Tonelli AR. Raeisi-Giglou P, et al. Among authors: bair n. Chest. 2017 May;151(5):1189-1192. doi: 10.1016/j.chest.2017.01.043. Chest. 2017. PMID: 28483121 Free PMC article. No abstract available.

2

Subdural hematomas in pulmonary arterial hypertension patients treated with prostacyclin analogs [corrected].

Louis L, Bair N, Banjac S, Dweik RA, Tonelli AR. Louis L, et al. Among authors: bair n. Pulm Circ. 2012 Oct;2(4):518-21. doi: 10.4103/2045-8932.105041. Pulm Circ. 2012. PMID: 23372937 Free PMC article.

3

Causes and circumstances of death in pulmonary arterial hypertension.

Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, Dweik RA. Tonelli AR, et al. Among authors: bair n. Am J Respir Crit Care Med. 2013 Aug 1;188(3):365-9. doi: 10.1164/rccm.201209-1640OC. Am J Respir Crit Care Med. 2013. PMID: 23600433 Free PMC article.

4

Subcutaneous to intravenous prostacyclin analog transition in pulmonary hypertension.

Alkukhun L, Bair ND, Dweik RA, Tonelli AR. Alkukhun L, et al. Among authors: bair nd. J Cardiovasc Pharmacol. 2014 Jan;63(1):4-8. doi: 10.1097/FJC.0000000000000018. J Cardiovasc Pharmacol. 2014. PMID: 24084219 Free PMC article.

5

Chronic Thromboembolic Pulmonary Hypertension: Part 1.

Heresi GA, Bair N, Dweik RA. Heresi GA, et al. Among authors: bair n. Am J Respir Crit Care Med. 2017 May 15;195(10):P19-P20. doi: 10.1164/rccm.19510P19. Am J Respir Crit Care Med. 2017. PMID: 28504603 No abstract available.

6

Inpatient Initiation of Oral Treprostinil in an Academic Medical System.

Hohlfelder B, Tonelli AR, Heresi GA, Bair N, Rahaghi FF, Bauer SR. Hohlfelder B, et al. Among authors: bair n. Cardiovasc Drugs Ther. 2020 Aug;34(4):547-553. doi: 10.1007/s10557-020-06992-0. Cardiovasc Drugs Ther. 2020. PMID: 32424651

7

Sleep quality, depression, and quality of life in patients with pulmonary hypertension.

Batal O, Khatib OF, Bair N, Aboussouan LS, Minai OA. Batal O, et al. Among authors: bair n. Lung. 2011 Apr;189(2):141-9. doi: 10.1007/s00408-010-9277-9. Epub 2010 Dec 21. Lung. 2011. PMID: 21174111

8

Prevalence and characteristics of restless legs syndrome in patients with pulmonary hypertension.

Minai OA, Malik N, Foldvary N, Bair N, Golish JA. Minai OA, et al. Among authors: bair n. J Heart Lung Transplant. 2008 Mar;27(3):335-40. doi: 10.1016/j.healun.2007.12.008. J Heart Lung Transplant. 2008. PMID: 18342758

9

Lessons learned in developing a chronic thromboembolic pulmonary hypertension program.

Bair ND, Heresi GA. Bair ND, et al. Curr Opin Pulm Med. 2023 Sep 1;29(5):355-362. doi: 10.1097/MCP.0000000000000983. Epub 2023 Jun 28. Curr Opin Pulm Med. 2023. PMID: 37395507 Review.

10

Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit: physician and nurse adherence.

Bair N, Bobek MB, Hoffman-Hogg L, Mion LC, Slomka J, Arroliga AC. Bair N, et al. Crit Care Med. 2000 Mar;28(3):707-13. doi: 10.1097/00003246-200003000-00018. Crit Care Med. 2000. PMID: 10752819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page